3-Ketothiolase Deficiency care technology platforms are the digital infrastructure underpinning modern management of 3-Ketothiolase Deficiency — the rare inborn error of isoleucine catabolism and ketone body metabolism caused by biallelic pathogenic variants in ACAT1 encoding mitochondrial acetoacetyl-CoA thiolase (also designated T2), the enzyme that catalyzes both the thiolytic cleavage of 2-methylacetoacetyl-CoA in the isoleucine degradation pathway and the reversible thiolytic cleavage of acetoacetyl-CoA in the ketone body utilization pathway — an enzymatic role at this bifunctional metabolic intersection that produces a clinically distinctive disorder in which patients accumulate 2-methylacetoacetate, tiglylglycine, and 2-methyl-3-hydroxybutyrate from impaired isoleucine catabolism while also exhibiting defective ketone body degradation producing elevated acetoacetate and beta-hydroxybutyrate during fasting or illness, generating episodic severe ketoacidotic crises with metabolic acidosis, vomiting, encephalopathy, and cardiovascular compromise that may be triggered by intercurrent illness, high-protein dietary intake, or prolonged fasting — with the characteristic organic aciduria profile of 2-methylacetoacetate, 2-methyl-3-hydroxybutyrate, and tiglylglycine in urine serving as the biochemical diagnostic signature that distinguishes ACAT1 Deficiency from other ketone body metabolism disorders — integrating ACAT1 Deficiency rare disease registry platforms, organic acid monitoring and ketone body crisis tracking systems, protein intake monitoring and isoleucine restriction compliance platforms, ketone level surveillance systems providing real-time early ketosis detection during illness or dietary indiscretion, metabolic crisis prevention platforms combining concurrent illness tracking with automatic dietary intervention escalation protocols, blood gas trending systems documenting the bicarbonate, pH, and anion gap dynamics of episodic ketoacidotic crises, emergency management protocol repositories providing carbohydrate loading and intravenous bicarbonate guidance for acute acidotic decompensation, and longitudinal outcome monitoring platforms tracking neurodevelopmental trajectory and crisis frequency in the context of dietary compliance quality. When a 3-Ketothiolase Deficiency care platform is unavailable or degraded, providers cannot access organic acid profiles, protein restriction guidelines, emergency ketoacidosis protocols, ketone monitoring data, or the dietary compliance documentation that guides management of this intermittently life-threatening metabolic disorder in which platform inaccessibility during a prodromal crisis phase can delay protein restriction and glucose loading that prevents full ketoacidotic decompensation.
This guide covers what 3-Ketothiolase Deficiency care technology platforms need to monitor, why continuous availability matters for a condition where episodic ketoacidotic crises can progress to severe acidosis and encephalopathy within hours of metabolic decompensation, and how to build a monitoring strategy that protects ketone surveillance platforms, organic acid monitoring systems, protein restriction compliance infrastructure, and the emergency protocol coordination workflows that ACAT1 Deficiency management requires.
Why 3-Ketothiolase Deficiency Care Tech Platforms Cannot Afford Downtime
3-Ketothiolase Deficiency management combines a chronic dietary protein restriction requirement — limiting isoleucine intake by controlling total protein consumption and particularly avoiding leucine-enriched high-protein foods that accelerate flux through the blocked isoleucine catabolism pathway — with an emergency response imperative that demands immediate family and provider access to crisis protocols whenever intercurrent febrile illness, dietary protein excess, prolonged fasting, or physiological stress threatens to trigger the episodic ketoacidotic crisis that is the hallmark clinical event in ACAT1 Deficiency. Both domains require continuous platform availability because the biochemical cascade from early ketosis to severe metabolic acidosis with pH below 7.1 can progress within hours, and emergency protocol access cannot be deferred to a business-hours platform restoration window during an active ketoacidotic episode.
Ketone body surveillance and blood gas trending are the metabolic safety backbone for crisis prediction. Unlike disorders where laboratory deterioration follows a predictable gradual trajectory, 3-Ketothiolase Deficiency crises accelerate rapidly during intercurrent illness because both the isoleucine pathway — generating organic acid load — and the ketone body degradation pathway are simultaneously impaired, doubling the metabolic acid burden during illness-driven catabolism. Home ketone monitoring platforms that detect early blood ketone elevation during illness enable protein intake restriction, carbohydrate supplementation, and early medical assessment before pH falls to the refractory acidosis range that requires intensive care management.
Protein intake monitoring and isoleucine restriction compliance are the chronic prevention infrastructure. Patients maintaining dietary protein restriction within their individually calculated tolerance — calibrated to keep isoleucine intake below the flux threshold that produces pathological 2-methylacetoacetate accumulation — have substantially lower crisis frequencies than patients with poor dietary adherence. Dietitian-facing platforms tracking daily protein intake, isoleucine load, food diary documentation, and growth-based restriction recalculation at each clinic visit constitute the preventive data infrastructure that identifies patients accumulating dietary protein burden beyond their enzymatic tolerance before the next febrile illness triggers a crisis on top of already-elevated organic acid background levels.
Emergency protocol accessibility is a direct life-safety requirement during acute crisis management. Emergency providers managing ACAT1 Deficiency ketoacidotic crises who cannot access condition-specific protocols face the dual risk of under-treating acidosis severity by applying generic organic acidemia protocols that underestimate the bicarbonate replacement requirement, and simultaneously under-restricting protein intake during crisis management — an important dietary modification given the isoleucine pathway contribution to organic acid accumulation that continues even during acute management if protein intake is not temporarily eliminated or severely restricted.
What to Monitor on a 3-Ketothiolase Deficiency Care Tech Platform
Ketone Monitoring and Blood Gas Trending Platform
The ketone body surveillance and metabolic acidosis progression tracking service — integrating home blood beta-hydroxybutyrate measurements at illness-triggered frequencies with automatic threshold alerting when ketone levels exceed 3.0 mmol/L indicating early ketosis requiring dietary intervention, arterial and venous blood gas result integration from emergency department and inpatient encounters documenting the pH, PCO2, bicarbonate, and base excess trajectory across acute episodes, serum anion gap calculation and trending identifying the elevated anion gap metabolic acidosis from accumulating 2-methylacetoacetate, acetoacetate, and organic acid intermediates, urine ketone dipstick result integration at illness-onset monitoring providing rapid point-of-care ketosis detection that triggers the family's emergency escalation protocol, blood 2-methylacetoacetate measurement at crisis encounters when available through point-of-care acylcarnitine or organic acid testing, crisis severity scoring linking blood gas parameters and clinical signs to the management intensity algorithm from home carbohydrate supplementation to emergency department assessment to intensive care unit admission for refractory acidosis, post-crisis normalization tracking documenting the timeline of pH, bicarbonate, and ketone recovery following acute intravenous management, and ketosis pattern analysis across illness episodes identifying precipitant types — viral infection, dietary protein excess, fasting, physical exertion — that most reliably trigger crisis in each patient — is the primary real-time clinical safety platform for ACAT1 Deficiency. Check at a 1-minute interval with immediate escalation when this platform fails. Ketone surveillance platform inaccessibility during a developing crisis eliminates the early warning that enables dietary and clinical intervention before metabolic acidosis becomes severe and refractory.
Emergency Protocol and Crisis Management Platform
Monitor the emergency protocol access and crisis management coordination service — including 3-Ketothiolase Deficiency emergency management letter repository accessible to families, emergency departments, urgent care centers, and pediatric intensive care units managing ketoacidotic crises in patients with this rare enzyme deficiency, acute protein restriction protocol documentation specifying the elimination of all dietary protein during crisis phases to remove isoleucine catabolism flux as a contributor to organic acid accumulation during acute metabolic decompensation, intravenous glucose infusion protocol specifying dextrose concentration and infusion rate as the carbohydrate energy source that suppresses catabolism and ketogenesis during crisis management, intravenous sodium bicarbonate administration protocol with pH and bicarbonate thresholds triggering its use given the debate around bicarbonate administration in organic acidemias and the specific guidance appropriate for ACAT1 Deficiency, carnitine supplementation protocol if used at the center for organic acid conjugation and urinary excretion facilitation during crisis, hospital admission criteria documentation outlining the blood gas and clinical severity parameters requiring inpatient metabolic management versus home management with increased monitoring, metabolic specialist on-call contact directory providing emergency consultation access for providers managing an infrequently encountered rare metabolic disorder, and post-crisis dietary protein reintroduction protocol documenting the graduated protein reintroduction schedule and monitoring requirements as the patient recovers from acute metabolic decompensation — at a 1-minute interval. Emergency protocol platform availability is a direct life-safety requirement; inaccessibility during an acute crisis forces providers to manage ketoacidotic decompensation in a rare metabolic disorder without condition-specific guidance.
Protein Intake and Dietary Restriction Compliance Platform
Monitor the protein intake monitoring and isoleucine restriction compliance service — including daily protein intake tracking with isoleucine content estimation based on food diary analysis and dietary record review at weekly intervals during stable management and daily intervals during illness-prone seasons, individualized protein tolerance documentation recording the patient's calculated maximum safe protein intake by current body weight — updated at each clinic encounter as growth-based recalculation adjusts the tolerance threshold, food log review platform enabling dietitians to analyze dietary records submitted by families between clinic visits for protein loading events that increase crisis risk, sick day dietary protocol compliance documentation tracking adherence to the protocol-specified protein elimination or severe restriction combined with increased carbohydrate intake during illness or metabolic stress, school meal monitoring coordination for pediatric patients ensuring cafeteria food selection complies with protein restriction guidelines, growth monitoring integration tracking height velocity and weight gain to identify patients approaching protein malnutrition from excessive restriction requiring upward protein tolerance adjustment, essential amino acid supplementation tracking for patients requiring amino acid mixtures to maintain nutritional adequacy within protein restriction parameters, and dietary compliance correlation with crisis frequency linking protein intake patterns to the temporal distribution of ketoacidotic episodes — at a 2-minute interval. Dietary protein restriction is the primary chronic prevention intervention in ACAT1 Deficiency; platform failures interrupt the compliance surveillance that identifies dietary protein drift before the next febrile illness triggers a crisis on top of elevated organic acid background levels.
Organic Acid Monitoring and Laboratory Result Integration Platform
Monitor the organic acid profiling and scheduled laboratory surveillance service — including urine organic acid quantitative analysis at 3-month stable-state intervals documenting the 2-methylacetoacetate, 2-methyl-3-hydroxybutyrate, and tiglylglycine concentrations that reflect isoleucine pathway substrate accumulation above the ACAT1 enzymatic block — with elevation relative to stable baseline indicating dietary protein excess or early stress-driven catabolism, plasma acylcarnitine profiling integration documenting tiglylcarnitine and 2-methyl-3-hydroxybutyrylcarnitine concentrations reflecting isoleucine pathway intermediate accumulation, beta-hydroxybutyrate and acetoacetate quantification at crisis encounters and at stable 3-month intervals documenting ketone body accumulation from the impaired ketone degradation arm of ACAT1 function, comprehensive metabolic panel integration tracking bicarbonate, glucose, creatinine, ammonia — occasionally elevated during severe organic acid crisis — albumin, and transaminase parameters, blood gas result integration at each crisis encounter documenting the metabolic acidosis severity, carnitine free and total measurements at 6-month intervals assessing secondary carnitine depletion from organic acid-carnitine conjugate urinary losses, and genetic testing result integration documenting the ACAT1 biallelic variant pair and their functional consequence classification — null versus hypomorphic — for genotype-phenotype correlation in the registry — at a 2-minute interval. Organic acid monitoring provides the biochemical characterization that distinguishes stable-state biochemistry from early stress-induced pathway activation and guides dietary restriction tightening before accumulation reaches crisis-triggering thresholds.
Intercurrent Illness Surveillance and Crisis Prevention Platform
Monitor the intercurrent illness detection and crisis prevention protocol coordination service — including illness diary and symptom reporting platform enabling families to report fever onset, vomiting, reduced oral intake, or behavioral changes that constitute the standard prodromal indicators for ketoacidotic crisis in ACAT1 Deficiency, automated sick day protocol trigger documentation recording the dietary and monitoring protocol modifications initiated at illness onset, home ketone measurement escalation protocol activation tracking documenting increased measurement frequency during illness phases and the ketone thresholds triggering emergency evaluation, emergency department visit coordination platform providing families with condition-specific preparation for emergency department encounters including what laboratory tests to request and what documentation to bring, illness-to-crisis conversion rate tracking linking illness episode reports to the proportion that progress to emergency department visits or hospital admissions — providing program quality metrics for crisis prevention protocol effectiveness, viral season preparation platform coordinating prophylactic dietary pre-loading and proactive dietitian contact scheduling during high-risk autumn and winter months, and illness recovery protocol coordination tracking the timeline of dietary protein reintroduction and monitoring de-escalation following resolution of intercurrent illness — at a 2-minute interval. Intercurrent illness is the most common precipitant of ketoacidotic crisis in ACAT1 Deficiency; a platform providing early illness detection and automatic protocol escalation is the most impactful preventive intervention in a disorder where crisis prevention is almost entirely about early recognition and rapid dietary and clinical response to illness onset.
Neurodevelopmental Surveillance and Long-term Outcome Platform
Monitor the neurodevelopmental outcome tracking and cognitive assessment integration service — including neuropsychological testing at 6-month intervals documenting cognitive trajectory, executive function, processing speed, and academic performance in patients who may have experienced repeated acidotic encephalopathy during poorly managed or pre-diagnosis ketoacidotic crises, MRI brain result integration documenting white matter signal abnormalities, basal ganglia involvement, or generalized volume loss associated with severe metabolic acidosis episodes causing hypoxic-ischemic or acidosis-induced brain injury, electroencephalography result integration documenting post-crisis epileptiform activity or established epilepsy resulting from neurological complications of severe metabolic acidosis, school performance monitoring and educational support coordination identifying students requiring accommodation for cognitive consequences of prior crisis burden, behavioral assessment documentation tracking anxiety, depression, and adjustment responses to the dietary restriction and medical management demands of living with a recurrent crisis disorder, developmental milestone tracking in pediatric patients during the early childhood years when ACAT1 Deficiency crises most commonly occur before dietary management fully prevents decompensation, early intervention service enrollment coordination for patients with identified developmental delays or neurocognitive consequences, and neurology co-management scheduling for patients with established epilepsy or persistent neurological complications from prior severe crises — at a 2-minute interval. Neurodevelopmental surveillance provides the longitudinal functional outcome data that quantifies the cumulative neurological impact of crisis burden and guides the intensity of dietary restriction and crisis prevention efforts necessary to protect brain function.
ACAT1 Registry and Genetic Counseling Platform
Monitor the rare disease registry and genetic counseling coordination service — including ACAT1 Deficiency rare disease registry enrollment and longitudinal phenotype data submission documenting crisis frequency, precipitant types, organic acid profiling results, dietary protein tolerance by age, blood gas nadir values during crisis, and neurodevelopmental assessment outcomes, ACAT1 biallelic variant documentation for genotype-phenotype correlation studies linking null versus hypomorphic variant pairs to crisis frequency and protein tolerance thresholds, family genetic counseling scheduling for parents heterozygous for ACAT1 variants with 25% recurrence risk per pregnancy, prenatal diagnosis coordination for at-risk pregnancies including molecular testing of chorionic villus sampling or amniocentesis material, newborn sibling management protocol activation enabling presymptomatic dietary management in siblings identified as ACAT1-biallelic through expanded newborn screening cascade, and natural history data contribution tracking the age-related evolution of dietary protein tolerance and the long-term neurodevelopmental trajectory in well-managed versus crisis-frequent patients — at a 5-minute interval. The ACAT1 Deficiency registry generates the clinical evidence base that characterizes optimal protein restriction thresholds by age and body weight, the organic acid surveillance parameters that predict crisis risk, and the neurodevelopmental outcome predictors that will refine management guidelines for this rare thiolase deficiency.
EHR Integration Endpoint
Monitor the EHR synchronization service at a 5-minute interval. ACAT1 Deficiency patients presenting to any emergency department or urgent care setting require immediate provider access to crisis protocols, current protein restriction parameters, organic acid profile history, blood gas trending data, carnitine supplementation records, metabolic specialist contact information, and ACAT1 genotype documentation that establishes the diagnosis for providers encountering this rare thiolase deficiency in an acute care context.
Authentication Service
Monitor authentication at a 1-minute interval. Auth failures simultaneously lock metabolic disease physicians, dietitians, emergency consultants, neurologists, and care coordinators out of ketone surveillance dashboards, protein restriction compliance platforms, emergency protocol repositories, organic acid result integration systems, and the neurodevelopmental surveillance platforms that collectively constitute the clinical safety infrastructure for 3-Ketothiolase Deficiency management.
SSL Certificates Across All Platform Domains
Monitor certificate expiry 30 days in advance across all patient-facing, clinician-facing, emergency protocol, and registry integration domains.
Alerting Strategy for 3-Ketothiolase Deficiency Care Tech Platforms
Immediate clinical escalation (24/7): Ketone monitoring and blood gas trending platform, emergency protocol and crisis management platform, authentication service. Ketone surveillance and emergency protocol access are direct life-safety functions in ACAT1 Deficiency; inaccessibility during a developing ketoacidotic crisis eliminates both early warning and acute management guidance.
Immediate clinical operations escalation: Intercurrent illness surveillance and crisis prevention platform. Illness detection and automatic protocol escalation is the most impactful preventive intervention for crisis prevention; platform failures eliminate the early response coordination that aborts crises at the prodromal stage.
High-priority escalation: Protein intake and dietary restriction compliance platform, organic acid monitoring and laboratory result integration platform. Failures interrupt the dietary compliance surveillance and biochemical monitoring that determine crisis frequency.
Business-hours escalation: Neurodevelopmental surveillance and long-term outcome platform, ACAT1 registry and genetic counseling platform, EHR synchronization. Investigate within one business hour.
Advance warning: SSL certificate expiry, 30 days in advance.
Status Page as a Clinical Safety Signal
3-Ketothiolase Deficiency families and metabolic care coordinators managing dietary protein restrictions and ketone monitoring during intercurrent illness episodes need immediate platform status visibility before concluding that emergency protocols cannot be accessed, ketone monitoring data is unavailable, or illness surveillance coordination cannot be initiated. Publish the status page URL in patient family communication materials, emergency department ACAT1 Deficiency patient flags, metabolic clinic workstations, and on-call metabolic specialist contact sheets.
The Business Case: Crisis Prevention and Neurodevelopmental Outcome Protection
ACAT1 Deficiency specialty programs face quality exposure from ketone surveillance platform failures that eliminate early ketosis detection during illness and allow acidosis to progress to pH levels requiring intensive care management before intervention is initiated, emergency protocol inaccessibility that forces emergency providers to manage ketoacidotic decompensation in a rare thiolase deficiency without condition-specific guidance about protein elimination, glucose loading, and bicarbonate management, dietary compliance monitoring failures that allow protein intake drift to increase the organic acid background burden that reduces the threshold for crisis during the next febrile illness, and neurodevelopmental surveillance failures that allow cognitive consequences of prior crisis episodes to go undetected and unsupported through educational and therapeutic intervention. Crisis frequency reduction and neurodevelopmental outcome quality are the primary metrics by which ACAT1 Deficiency specialty programs are evaluated; programs whose monitoring platforms frequently fail cannot demonstrate the continuous ketone surveillance, dietary compliance management, illness-triggered protocol escalation, and emergency protocol access that characterize excellence in mitochondrial acetoacetyl-CoA thiolase deficiency management. External monitoring from Vigilmon provides the independent availability record that ACAT1 Deficiency program directors can present to metabolic disease networks and rare disease advocacy organizations as evidence of continuous digital infrastructure supporting the crisis prevention, emergency response, and neurodevelopmental surveillance that 3-Ketothiolase Deficiency patients require.
Vigilmon Setup for 3-Ketothiolase Deficiency Care Tech Platforms
A practical starting configuration:
| Monitor | Check Interval | Alert Channel | |---------|----------------|---------------| | Ketone monitoring and blood gas trending platform | 1 min | PagerDuty (immediate, 24/7) | | Emergency protocol and crisis management platform | 1 min | PagerDuty (immediate, 24/7) | | Auth service | 1 min | PagerDuty (immediate) | | Intercurrent illness surveillance and crisis prevention platform | 2 min | PagerDuty (immediate) | | Protein intake and dietary restriction compliance platform | 2 min | PagerDuty (immediate) | | Organic acid monitoring and laboratory result integration | 2 min | PagerDuty (immediate) | | Neurodevelopmental surveillance and long-term outcome platform | 2 min | Slack (business hours) | | ACAT1 registry and genetic counseling platform | 5 min | Slack (business hours) | | EHR synchronization endpoint | 5 min | Slack (business hours) | | SSL: all platform domains | Daily | Email (30-day warning) |
Getting started:
- Create a free account at vigilmon.online
- Add ketone monitoring and blood gas trending at a 1-minute interval — real-time ketosis detection is the life-safety foundation for crisis prevention in ACAT1 Deficiency
- Add emergency protocol and crisis management platform monitoring at a 1-minute interval covering protein restriction protocols, intravenous glucose guidelines, and bicarbonate management
- Add intercurrent illness surveillance and crisis prevention monitoring at a 2-minute interval covering sick day protocol activation and illness-to-crisis prevention coordination
- Add protein intake and dietary restriction compliance monitoring at a 2-minute interval covering daily protein tracking, isoleucine load estimation, and food diary review
- Add organic acid monitoring and laboratory result integration at a 2-minute interval covering urine organic acids, acylcarnitines, and blood gas trending
- Add neurodevelopmental surveillance monitoring at a 2-minute interval covering cognitive assessments, MRI results, and educational support coordination
- Add ACAT1 registry and genetic counseling coordination at a 5-minute interval
- Add authentication and EHR synchronization
- Enable SSL monitoring across all patient-facing and emergency protocol domains
- Publish the automatic status page URL in family materials and emergency department ACAT1 Deficiency patient flags
Conclusion
3-Ketothiolase Deficiency care tech platforms hold the clinical coordination infrastructure that makes comprehensive, crisis-preventing management possible for patients with this rare ACAT1-deficient thiolase disorder — ketone monitoring and blood gas trending platforms providing the real-time ketosis and metabolic acidosis surveillance that detects early crisis trajectories during intercurrent illness before pH falls to the refractory acidosis range requiring intensive care management in patients whose dual enzymatic defect in isoleucine catabolism and ketone body degradation generates a compounded organic acid burden during catabolic stress that escalates more rapidly than single-pathway organic acidemias, emergency protocol and crisis management platforms providing condition-specific acute management guidance to families and emergency providers who must simultaneously eliminate dietary protein, initiate glucose loading, and assess the bicarbonate threshold for intravenous alkali supplementation in a rare metabolic disorder they encounter infrequently in the acute care setting, protein intake and dietary restriction compliance platforms enabling dietitians to track daily isoleucine load, protein tolerance threshold adherence, sick day protein elimination compliance, and the growth-based restriction recalculation that ensures protein restriction parameters evolve appropriately as patients grow through childhood and adolescence, intercurrent illness surveillance and crisis prevention platforms providing the early illness detection and automatic protocol escalation infrastructure that is most effective at preventing the conversion of febrile illness from a manageable dietary adjustment event to a hospital admission for intravenous bicarbonate and glucose management, organic acid monitoring and laboratory result integration platforms documenting the 2-methylacetoacetate, tiglylglycine, and 2-methyl-3-hydroxybutyrate profiles that characterize each patient's stable-state biochemistry and identify early stress-driven pathway activation before ketone and blood gas parameters reflect crisis severity, neurodevelopmental surveillance platforms tracking the cognitive and neurological trajectory of patients who have experienced prior acidotic encephalopathy and identifying the educational and therapeutic support resources proportionate to their cumulative crisis burden, and ACAT1 Deficiency registry platforms generating the natural history evidence that characterizes optimal protein restriction thresholds, crisis precipitant patterns, and the neurodevelopmental outcome predictors that will ultimately refine management guidelines for this rare but clinically significant bifunctional thiolase deficiency — platforms that cannot undo the crisis progression from delayed emergency protocol access, the dietary drift from unavailable compliance monitoring, the missed early ketosis from offline surveillance, or the undetected neurological consequences from failed neurodevelopmental assessment, in a condition where the care team's commitment to continuous ketone surveillance, reliable crisis protocol access, and stringent dietary compliance monitoring is the defining standard of excellence in mitochondrial acetoacetyl-CoA thiolase deficiency care. External monitoring from Vigilmon provides the independent, outside-in availability view that ACAT1 Deficiency program directors need to catch platform failures before they affect ketone surveillance, emergency protocol access, or the dietary compliance monitoring that makes 3-Ketothiolase Deficiency a condition where excellent metabolic management produces meaningfully fewer and less severe ketoacidotic crises and better preserved neurodevelopmental outcomes across the lifetime of ACAT1-deficient patients.
Start monitoring your 3-Ketothiolase Deficiency care tech platform for free at vigilmon.online — HTTP/HTTPS monitoring, multi-region consensus alerting, SSL certificate monitoring, automatic status page, Slack and PagerDuty integration. No agent required. No credit card.
Tags: #monitoring #3KetothiolaseDeficiency #ACAT1 #mitochondrialThiolase #ketoacidosis #isoleucineMetabolism #organicAcidemia #ketoneBodyMetabolism #tiglylglycine #2methylacetoacetate #inbornErrorsOfMetabolism #rareDisease #metabolicDisease #dietaryProteinRestriction #metabolicCrisis #healthtech #uptime #sre